The Melanocortin Receptor Genes Are Linked to and Associated with the Risk of Polycystic Ovary Syndrome in Italian Families

Overview

Journal J Ovarian Res

Publisher Biomed Central

Specialties Gynecology & Obstetrics
Reproductive Medicine

Date 2024 Dec 5

PMID 39633478

Authors

Rongling Wu

Claudia Gragnoli

Affiliations

Soon will be listed here.

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder occurring in women of reproductive age. The disease is caused by a complex interplay of genetic and environmental factors including genes encoding components of the hypothalamic-pituitary-adrenal (HPA) axis. We have recently reported the association of melanocortin receptor genes (MC1R, MC2R, MC3R, MC4R, and MC5R) with the risk of type 2 diabetes (T2D) and/or major depressive disorder (MDD). The latter 2 disorders are comorbid with PCOS. In this study, we used microarray to test 12 single nucleotide polymorphisms (SNPs) in the MC1R gene, 10 SNPs in the MC2R gene, 5 SNPs in the MC3R gene, 6 SNPs in the MC4R gene, and 4 SNPs in the MC5R gene in 212 original Italian families with PCOS. We identified 1 SNP in MC1R, 1 SNP in MC2R, 2 SNPs in MC3R, and 2 SNPs in MC5R significantly linked and/or associated to/with the risk of PCOS in Italian families. This is the first study to report the novel implication of melanocortin receptor genes (MC1R, MC2R, and MC5R) in PCOS. MC3R and MC4R were previously reported in PCOS. However, functional studies are needed to validate these results.

References

Cooney L, Dokras A . Depression and Anxiety in Polycystic Ovary Syndrome: Etiology and Treatment. Curr Psychiatry Rep. 2017; 19(11):83. DOI: 10.1007/s11920-017-0834-2. View

Metzger P, Zhang A, Carlson B, Sun H, Cui Z, Li Y . A human obesity-associated MC4R mutation with defective Gq/11α signaling leads to hyperphagia in mice. J Clin Invest. 2024; 134(4). PMC: 10869179. DOI: 10.1172/JCI165418. View

Amin M, Syed S, Wu R, Postolache T, Gragnoli C . Familial Linkage and Association of the Gene with Type 2 Diabetes and Depression Comorbidity. Int J Mol Sci. 2022; 23(19). PMC: 9569497. DOI: 10.3390/ijms231911951. View

Hepsen S, Cakal E, Karakose M, Eyerci N, Saat H, Beysel S . Melanocortin 3 receptor gene polymorphism is associated with polycystic ovary syndrome in Turkish population. Gynecol Endocrinol. 2019; 35(8):685-690. DOI: 10.1080/09513590.2019.1576614. View

Tokmak A, Guzel A, Guney G, Tasdemir U, Umit C, Yilmaz N . Effect of Obesity on Clinical Parameters and Pregnancy Rates in Women with Polycystic Ovary Syndrome Undergoing Ovulation Induction Cycles. J Reprod Med. 2018; 62(5-6):300-4. View

Jaseem Khan M, Ullah A, Basit S . Genetic Basis of Polycystic Ovary Syndrome (PCOS): Current Perspectives. Appl Clin Genet. 2020; 12:249-260. PMC: 6935309. DOI: 10.2147/TACG.S200341. View

Camili F, Akis M, Adali E, Hismiogullari A, Islimye Taskin M, Guney G . Oncostatin M Is Related to Polycystic Ovary Syndrome-Case Control Study. Biomedicines. 2024; 12(2). PMC: 10886802. DOI: 10.3390/biomedicines12020355. View

Hiekkalinna T, Schaffer A, Lambert B, Norrgrann P, Goring H, Terwilliger J . PSEUDOMARKER: a powerful program for joint linkage and/or linkage disequilibrium analysis on mixtures of singletons and related individuals. Hum Hered. 2011; 71(4):256-66. PMC: 3190175. DOI: 10.1159/000329467. View

Girardet C, Butler A . Neural melanocortin receptors in obesity and related metabolic disorders. Biochim Biophys Acta. 2013; 1842(3):482-94. PMC: 3819409. DOI: 10.1016/j.bbadis.2013.05.004. View

10.

Kolhe J, Chhipa A, Butani S, Chavda V, Patel S . PCOS and Depression: Common Links and Potential Targets. Reprod Sci. 2021; 29(11):3106-3123. DOI: 10.1007/s43032-021-00765-2. View

11.

Turcu A, Smith J, Auchus R, Rainey W . Adrenal androgens and androgen precursors-definition, synthesis, regulation and physiologic actions. Compr Physiol. 2014; 4(4):1369-81. PMC: 4437668. DOI: 10.1002/cphy.c140006. View

12.

Rosmond R . Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology. 2004; 30(1):1-10. DOI: 10.1016/j.psyneuen.2004.05.007. View

13.

Ayers K, Glicksberg B, Garfield A, Longerich S, White J, Yang P . Melanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment. J Clin Endocrinol Metab. 2018; 103(7):2601-2612. PMC: 7263790. DOI: 10.1210/jc.2018-00258. View

14.

Batarfi A, Filimban N, Bajouh O, Dallol A, Chaudhary A, Bakhashab S . MC4R variants rs12970134 and rs17782313 are associated with obese polycystic ovary syndrome patients in the Western region of Saudi Arabia. BMC Med Genet. 2019; 20(1):144. PMC: 6701028. DOI: 10.1186/s12881-019-0876-x. View

15.

Hart R . PCOS and infertility. Panminerva Med. 2008; 50(4):305-14. View

16.

Franik G, Krysta K, Madej P, Gimlewicz-Pieta B, Oslizlo B, Trukawka J . Sleep disturbances in women with polycystic ovary syndrome. Gynecol Endocrinol. 2016; 32(12):1014-1017. DOI: 10.1080/09513590.2016.1196177. View

17.

Mun Y, Kim W, Shin D . Melanocortin 1 Receptor (MC1R): Pharmacological and Therapeutic Aspects. Int J Mol Sci. 2023; 24(15). PMC: 10418475. DOI: 10.3390/ijms241512152. View

18.

Gragnoli C . Hypothesis of the neuroendocrine cortisol pathway gene role in the comorbidity of depression, type 2 diabetes, and metabolic syndrome. Appl Clin Genet. 2014; 7:43-53. PMC: 4012344. DOI: 10.2147/TACG.S39993. View

19.

Nooranizadeh M, Rahmanifar F, Ahmadloo S, Shaaban Z, Jafarzadeh Shirazi M, Tamadon A . Enhancement of Melanocortin-4 Receptor (MC4R) and Constancy of Kiss1 mRNAs Expression in the Hypothalamic Arcuate Nucleus in a Model of Polycystic Ovary Syndrome Rat. Galen Med J. 2021; 7:e1070. PMC: 8344174. DOI: 10.22086/gmj.v0i0.1070. View

20.

Wang N, Tong R, Xu J, Tian Y, Pan J, Cui J . PDX1 and MC4R genetic polymorphisms are associated with type 2 diabetes mellitus risk in the Chinese Han population. BMC Med Genomics. 2021; 14(1):249. PMC: 8543917. DOI: 10.1186/s12920-021-01037-3. View